These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3779033

  • 21. The effect of activated charcoal on drug exposure following intravenous administration: A meta-analysis.
    Skov K, Graudal NA, Jürgens G.
    Basic Clin Pharmacol Toxicol; 2021 Apr; 128(4):568-578. PubMed ID: 33386684
    [Abstract] [Full Text] [Related]

  • 22. Effect of pyrethroids on pentobarbital-induced sleeping time in relation to the chemical structure.
    Tsuji R, Isobe N, Kawasaki H.
    Toxicology; 1996 Jan 08; 106(1-3):131-7. PubMed ID: 8571384
    [Abstract] [Full Text] [Related]

  • 23. A study of the factors affecting the sleeping time following intracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally active drugs.
    Stevenson IH, Turnbull MJ.
    Br J Pharmacol; 1974 Apr 08; 50(4):499-511. PubMed ID: 4155651
    [Abstract] [Full Text] [Related]

  • 24. Involvement of peripheral type of benzodiazepine receptor in social isolation stress-induced decrease in pentobarbital sleep in mice.
    Dong E, Matsumoto K, Watanabe H.
    Life Sci; 1999 Apr 08; 65(15):1561-8. PubMed ID: 10574222
    [Abstract] [Full Text] [Related]

  • 25. Comparative clinical study of two hypnotic drugs.
    BAN TA, McGINNIS K.
    Can Med Assoc J; 1962 Oct 13; 87(15):816-7. PubMed ID: 13966278
    [Abstract] [Full Text] [Related]

  • 26. The removal of hypnotic drugs from human serum. A comparative investigation of the adsorptive properties of native and agarose-encapsulated resins and charcoal.
    Harstick K, Holloway CJ, Brunner G, Külpmann WR, Petry K.
    Int J Artif Organs; 1979 Mar 13; 2(2):87-95. PubMed ID: 38209
    [Abstract] [Full Text] [Related]

  • 27. Effects of three hypnotics on the sleep-wakefulness cycle in sleep-disturbed rats.
    Shinomiya K, Shigemoto Y, Omichi J, Utsu Y, Mio M, Kamei C.
    Psychopharmacology (Berl); 2004 Apr 13; 173(1-2):203-9. PubMed ID: 14722706
    [Abstract] [Full Text] [Related]

  • 28. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F, Jung N, Neuberger H, Witte A, Poethko T, Henke J, Zilker T.
    Basic Clin Pharmacol Toxicol; 2008 Mar 13; 102(3):337-46. PubMed ID: 18248517
    [Abstract] [Full Text] [Related]

  • 29. Interaction of ethanol with amylobarbitone, phenobarbitone and methaqualone.
    Tilstone WJ, Reavey PC.
    Res Commun Chem Pathol Pharmacol; 1978 Feb 13; 19(2):233-42. PubMed ID: 644120
    [Abstract] [Full Text] [Related]

  • 30. Effect of Activated Charcoal on Rivaroxaban Complex Absorption.
    Ollier E, Hodin S, Lanoiselée J, Escal J, Accassat S, De Magalhaes E, Basset T, Bertoletti L, Mismetti P, Delavenne X.
    Clin Pharmacokinet; 2017 Jul 13; 56(7):793-801. PubMed ID: 27910037
    [Abstract] [Full Text] [Related]

  • 31. Phenobarbital sensitivity in HAS and LAS rats before and after chronic administration of ethanol.
    Draski LJ, Deitrich RA, Ménez JF.
    Pharmacol Biochem Behav; 1997 Aug 13; 57(4):651-7. PubMed ID: 9258990
    [Abstract] [Full Text] [Related]

  • 32. A CLINICAL EVALUATION OF FOUR HYPNOTIC AGENTS, USING A LATIN-SQUARE DESIGN.
    LERICHE WH, CSIMA A.
    Can Med Assoc J; 1964 Aug 29; 91(9):435-8. PubMed ID: 14179064
    [Abstract] [Full Text] [Related]

  • 33. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
    Sketris IS, Mowry JB, Czajka PA, Anderson WH, Stafford DT.
    J Clin Pharmacol; 1982 Jan 29; 22(1):59-64. PubMed ID: 7061727
    [Abstract] [Full Text] [Related]

  • 34. Ferulic acid potentiates pentobarbital-induced sleep via the serotonergic system.
    Tu Y, Cheng SX, Sun HT, Ma TZ, Zhang S.
    Neurosci Lett; 2012 Sep 13; 525(2):95-9. PubMed ID: 22897877
    [Abstract] [Full Text] [Related]

  • 35. Activated charcoal surface area and its role in multiple-dose charcoal therapy.
    Ilkhanipour K, Yealy DM, Krenzelok EP.
    Am J Emerg Med; 1993 Nov 13; 11(6):583-5. PubMed ID: 8240556
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal.
    Pond SM, Olson KR, Osterloh JD, Tong TG.
    JAMA; 1984 Jun 15; 251(23):3104-8. PubMed ID: 6726981
    [Abstract] [Full Text] [Related]

  • 38. Clinical and statistical evaluation of six hypnotic agents.
    le RICHE W, van BELLE.
    Can Med Assoc J; 1963 Apr 20; 88(16):837-41. PubMed ID: 13982136
    [Abstract] [Full Text] [Related]

  • 39. Effect of sorbitol, single, and multidose activated charcoal administration on carprofen absorption following experimental overdose in dogs.
    Koenigshof AM, Beal MW, Poppenga RH, Jutkowitz LA.
    J Vet Emerg Crit Care (San Antonio); 2015 Apr 20; 25(5):606-10. PubMed ID: 25891141
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.